The U.S. Food and Drug Administration has downgraded the classification of full-field digital mammography devices from high risk to medium risk, making it easier for companies to bring the technology to market, the agency announced today.
FDA eases rules on digital mammography devices
Nov 3, 2010
Latest in Breast
Hologic highlights results from a study on AI-powered mammography
December 16, 2025
Study highlights risk-based breast cancer screening; ACR responds
December 12, 2025
Radiologists can designate nonmass lesions on breast ultrasound
December 9, 2025
ACR talks BI-RADS version 2025 with AuntMinnie
December 8, 2025
















